+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Regenerative Medicine Market by Type [Cell-Based Immunotherapy & Cell Therapy (Allogeneic & Autologous Products), Tissue Engineering, Gene Therapy], Applications (Wounds & Dermal, Musculoskeletal, Oncology), Region - Global Forecast to 2024

  • ID: 4760917
  • Report
  • Region: Global
  • 108 Pages
  • Markets and Markets
1 of 6
The Regenerative Medicine Market is Projected to Reach USD 38.7 Billion by 2024 from USD 13.3 Billion in 2019, at a CAGR of 23.8%

FEATURED COMPANIES

  • Integra Lifesciences
  • Mimedx Group
  • Novartis AG
  • Organogenesis
  • Osiris Therapeutics
  • Spark Therapeutics
  • MORE

“Regenerative medicine market to register a CAGR of 23.8% from 2019 to 2024”

The regenerative medicine market is projected to reach USD 38.7 billion by 2024 from USD 13.3 billion in 2019, at a CAGR of 23.8% during the forecast period. The rising global incidence of cancer, increasing global aging population, and technological shifts in regenerative medicine such as CAR-T cell therapy are factors expected to drive market growth during the forecast period. Economies with growing healthcare sector and high disposable income are also expected to provide opportunities for the growth of the market.

“Cell-based immunotherapy & cell therapy products likely to grow at a CAGR during the forecast period”

By type, the regenerative medicine market is segmented into cell-based immunotherapy & cell therapy products, tissue-engineered products, and gene therapy products. The cell-based immunotherapy & cell therapy products segment dominates this market in 2019 and is the fastest growing segment due to increasing launches of novel cell therapies, increasing demand for novel treatments with fewer side effects for the treatment of cancer are the major factors driving the growth of this market segment.

“Musculoskeletal Disorders application segment accounted for the largest share of the regenerative medicine market in 2019 and the oncology segment expected to achieve the highest growth rate in the future”

By application, the regenerative medicine market is segmented into musculoskeletal disorders, wound care, oncology, ocular disorders, diabetes, and other applications. Musculoskeletal disorder applications segment likely to account for the largest share of this market and oncology is likely to register the highest CAGR during the forecast period. The surging incidence rate of orthopedic diseases & injuries and rising geriatric population are the key drivers for the growth of this market segment.

“North America is expected to attain fastest growth rate and dominated the regenerative medicine market in 2019”

North America, which includes the US, & Canada, accounted for the largest share of the regenerative medicine market. The large share of this market segment can be attributed to the increasing incidence of chronic wounds, diabetes, leukemia and musculoskeletal diseases in this region.

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Company Type: Tier 1 (20%) , Tier 2 (45%), and Tier 3 (35%)
  • By Designation: C-level (30%), Director-level (20%), and Others (50%)
  • By Region: North America (35%), Europe (24%), Asia (25%), and RoW (16%)

The major players in this market are Kite Pharma (US), Novartis (Switzerland), Vericel Corporation (US), Integra LifeSciences (US), Wright Medical (US), MiMedx (US), Osiris Therapeutics (US), Stryker Corporation (US), and Spark Therapeutics (US). Product launches and acquisitions are the key growth strategies followed by most players in this market.

Research Coverage

This report studies the regenerative medicine market based on type and region. The report also analyzes factors (such as drivers, restraints, and opportunities) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micro-markets with respect to their growth trends, prospects, and contributions to the total regenerative medicine market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on regenerative medicines offered by the top 10 players in the regenerative medicine market. The report analyzes the regenerative medicine market by type, application, and region
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various regenerative medicine across key geographic regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the regenerative medicine market
  • Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the regenerative medicine market
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Integra Lifesciences
  • Mimedx Group
  • Novartis AG
  • Organogenesis
  • Osiris Therapeutics
  • Spark Therapeutics
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders

2 Research Methodology
2.1 Secondary Data
2.1.1 Key Data From Secondary Sources
2.2 Primary Data
2.2.1 Key Data From Primary Sources
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Market Breakdown and Data Triangulation
2.5 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Regenerative Medicine: Market Overview
4.2 Regenerative Medicine Market, By Type & Application (2019)
4.3 Geographical Snapshot of the Regenerative Medicine Market

5 Market Overview
5.1 Introduction
5.2 Clinical Trials for Regenerative Medicine
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Rising Prevalence of Chronic Diseases and Genetic Disorders
5.3.1.2 Rising Government Investments in Regenerative Medicine Research
5.3.1.3 Product Approvals and Growing Pipeline of Regenerative Medicine Products
5.3.2 Restraints
5.3.2.1 Ethical Concerns Related to the Use of Embryonic Stem Cells in Research & Development
5.3.3 Opportunities
5.3.3.1 Implementation of the 21st Century Cures Act
5.3.3.2 Rising Demand for Organ Transplantation

6 Regenerative Medicine Market, By Type
6.1 Introduction
6.2 Cell-Based Immunotherapy & Cell Therapy Products
6.2.1 Allogeneic Products
6.2.2 Autologous Products
6.3 Tissue-Engineered Products
6.4 Gene Therapy Products

7 Regenerative Medicine Market, By Application
7.1 Introduction
7.2 Musculoskeletal Disorders
7.2.1 Musculoskeletal Disorders Segment Will Continue to Dominate the Regenerative Medicine Market in 2024
7.3 Wound Care
7.3.1 Increasing Prevalence of Target Conditions to Drive the Growth of This Application Segment
7.4 Oncology
7.4.1 Increasing Prevalence of Cancer to Support Market Growth
7.5 Ocular Disorders
7.5.1 Growing Number of Product Approvals to Support Market Growth
7.6 Diabetes
7.6.1 Increasing Incidence of Diabetes and the Growing Focus of Companies on Developing Regenerative Medicine for the Treatment of Diabetes are the Key Factors Driving Market Growth
7.7 Other Applications

8 Regenerative Medicine Market, By Region
8.1 Introduction
8.2 North America
8.2.1 US
8.2.1.1 US Accounts for the Largest Share of the Regenerative Medicine Market in North America
8.2.2 Canada
8.2.2.1 Increasing R&D Funding for Regenerative Medicine is A Key Factor Influencing the Growth of the Canadian Regenerative Medicine Market
8.3 Europe
8.3.1 UK
8.3.1.1 UK Accounts for the Largest Market Share in the European Market
8.3.2 Germany
8.3.2.1 Germany has A Strong Foundation for R&D, Including Over 1,000 Public and Private Institutions
8.3.3 France
8.3.3.1 Rising R&D Expenditure, A Major Growth Driver in France
8.3.4 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.1.1 Comparatively Lenient Regulations and Rising Geriatric Population Will Drive Market Growth
8.4.2 China
8.4.2.1 Favorable Investments and Government Support Will Contribute to the Growth of the Chinese Market
8.4.3 Australia
8.4.3.1 Strong Research Base and Availability of Funds Will Push Market Growth in Australia
8.4.4 RoAPAC
8.5 Rest of the World

9 Competitive Landscape
9.1 Overview
9.2 Market Ranking Analysis, 2017
9.3 Key Strategies
9.3.1 Product Launches
9.4 Competitive Leadership Mapping (2018)
9.4.1 Vendor Inclusion Criteria
9.4.2 Visionary Leaders
9.4.3 Innovators
9.4.4 Dynamic Differentiators
9.4.5 Emerging Companies
9.5 Competitive Leadership Mapping for Start-Ups (2018)
9.5.1 Progressive Companies
9.5.2 Starting Blocks
9.5.3 Responsive Companies
9.5.4 Dynamic Companies

10 Company Profiles
10.1 Novartis AG
10.2 Vericel
10.3 Integra Lifesciences
10.4 Mimedx Group
10.5 Stryker
10.6 Wright Medical
10.7 Spark Therapeutics
10.8 Osiris Therapeutics
10.9 Kite Pharma (Subsidiary of Gilead Sciences)
10.10 Organogenesis

11 Appendix
11.1 Insights From Industry Experts
11.2 Discussion Guide
11.3 Available Customizations
11.4 Related Reports
11.5 Author Details

List of Tables
Table 1 Few Important Clinical Studies in the Regenerative Medicine: Market
Table 2 Cancer Incidence and Mortality, By Region, 2012-2035
Table 3 Funding for Regenerative Medicine Research By the Nih Under the 21st Century Cures Act
Table 4 Nih Funding for Regenerative Medicine Research in the Us, 2014-2016 (USD Million)
Table 5 California Institute of Regenerative Medicine Funding for Regenerative Medicine Research
Table 6 Number of Companies Operating in the Regenerative Medicine: Market, By Region (2014-2018)
Table 7 Market, By Type, 2017-2024 (USD Billion)
Table 8 Few of the Commercialized Cell-Based Immunotherapy & Cell Therapy Products
Table 9 Cell-Based Immunotherapy & Cell Therapy Products Market, By Region, 2017-2024 (USD Billion)
Table 10 Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 2017-2024 (USD Billion)
Table 11 Cell-Based Allogeneic Regenerative Medicine
Table 12 Allogeneic Products Market, By Region, 2017-2024 (USD Billion)
Table 13 Cell-Based Autologous Regenerative Medicine
Table 14 Autologous Products Market, By Region, 2017-2024 (USD Billion)
Table 15 Few of the Commercialized Tissue-Engineered Products
Table 16 Market for Tissue-Engineered Products, By Region, 2017-2024 (USD Billion)
Table 17 Few of the Commercialized Gene Therapy Products
Table 18 Market for Gene Therapy Products, By Region, 2017-2024 (USD Billion)
Table 19 Market, By Application, 2017-2024 (USD Billion)
Table 20 Market for Musculoskeletal Disorders, By Region, 2017-2024 (USD Billion)
Table 21 Regenerative Medicine Products Commercialized for the Treatment of Acute & Chronic Wounds
Table 22 Market for Wound Care, By Region, 2017-2024 (USD Billion)
Table 23 Number of Cancer Patients, By Type, 2012-2030
Table 24 Indicative List of Commercialized Regenerative Cell-Based Immunotherapies for the Treatment of Cancer
Table 25 Market for Oncology, By Region, 2017-2024 (USD Billion)
Table 26 Market for Ocular Disorders, By Region, 2017-2024 (USD Billion)
Table 27 Market for Diabetes, By Region, 2017-2024 (USD Billion)
Table 28 Market for Other Applications, By Region, 2017-2024 (USD Billion)
Table 29 Market, By Region, 2017-2024 (USD Billion)
Table 30 North America: Market, By Country, 2017-2024 (USD Billion)
Table 31 North America: Market, By Type, 2017-2024 (USD Billion)
Table 32 North America: Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 2017-2024 (USD Billion)
Table 33 North America: Regenerative Medicine, By Application, 2017-2024 (USD Billion)
Table 34 Products With Rmat Designation (As of 2018)
Table 35 US: Market, By Type, 2017-2024 (USD Billion)
Table 36 US: Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 2017-2024 (USD Billion)
Table 37 US: Market, By Application, 2017-2024 (USD Billion)
Table 38 Canada: Market, By Type, 2017-2024 (USD Billion)
Table 39 Canada: Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 2017-2024 (USD Billion)
Table 40 Canada: Market, By Application, 2017-2024 (USD Billion)
Table 41 Research Funding European Overview
Table 42 Europe: Market, By Country, 2017-2024 (USD Billion)
Table 43 Europe: Market, By Type, 2017-2024 (USD Billion)
Table 44 Europe: Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 2017-2024 (USD Billion)
Table 45 Europe: Regenerative Medicine, By Application, 2017-2024 (USD Billion)
Table 46 UK: Market, By Type, 2017-2024 (USD Billion)
Table 47 UK: Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 2017-2024 (USD Billion)
Table 48 UK: Market, By Application, 2017-2024 (USD Billion)
Table 49 Germany: Market, By Type, 2017-2024 (USD Billion)
Table 50 Germany: Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 2017-2024 (USD Billion)
Table 51 Germany: Market, By Application, 2017-2024 (USD Billion)
Table 52 France: Market, By Type, 2017-2024 (USD Billion)
Table 53 France: Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 2017-2024 (USD Billion)
Table 54 France: Market, By Application, 2017-2024 (USD Billion)
Table 55 RoE: Market, By Type, 2017-2024 (USD Billion)
Table 56 RoE: Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 2017-2024 (USD Billion)
Table 57 RoE: Market, By Application, 2017-2024 (USD Billion)
Table 58 APAC: Market, By Country, 2017-2024 (USD Billion)
Table 59 APAC: Market, By Type, 2017-2024 (USD Billion)
Table 60 APAC: Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 2017-2024 (USD Billion)
Table 61 APAC: Market, By Application, 2017-2024 (USD Billion)
Table 62 Japan: Market, By Type, 2017-2024 (USD Billion)
Table 63 Japan: Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 2017-2024 (USD Billion)
Table 64 Japan: Market, By Application, 2017-2024 (USD Billion)
Table 65 China: Market, By Type, 2017-2024 (USD Billion)
Table 66 China: Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 2017-2024 (USD Billion)
Table 67 China: Market, By Application, 2017-2024 (USD Billion)
Table 68 Australia: Market, By Type, 2017-2024 (USD Billion)
Table 69 Australia: Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 2017-2024 (USD Billion)
Table 70 Australia: Market, By Application, 2017-2024 (USD Billion)
Table 71 RoAPAC: Market, By Type, 2017-2024 (USD Billion)
Table 72 RoAPAC: Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 2017-2024 (USD Billion)
Table 73 RoAPAC: Market, By Application, 2017-2024 (USD Billion)
Table 74 RoW: Market, By Type, 2017-2024 (USD Billion)
Table 75 RoW: Cell-Based Immunotherapy & Cell Therapy Products Market, By Type, 2017-2024 (USD Billion)
Table 76 RoW: Market, By Application, 2017-2024 (USD Billion)

List of Figures
Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market: Bottom-Up Approach
Figure 4 Market: Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Market, By Type, 2019 vs 2024 (USD Billion)
Figure 7 Market, By Application, 2019 vs 2024 (USD Billion)
Figure 8 Market, By Region, 2019 vs 2024 (USD Billion)
Figure 9 Growing Government Investments in Regenerative Medicine Research to Drive Market Growth During the Forecast Period
Figure 10 Musculoskeletal Disorders to Dominate the Regenerative Medicine: Market in 2019
Figure 11 Countries in Europe to Register A Higher Growth Rate During the Forecast Period
Figure 12 Market: Drivers, Restraints, and Opportunities
Figure 13 Cell-Based Immunotherapy & Cell Therapy Products Segment to Dominate the Market in 2018
Figure 14 Oncology Segment to Register the Highest Growth in the Regenerative Medicine Market During the Forecast Period
Figure 15 Prevalence of Diabetes, By Region, 2015 vs 2040
Figure 16 North America to Witness the Highest Growth in the Regenerative Medicine Market During the Forecast Period
Figure 17 Investment Levels Quadrupled During 2010-2016
Figure 18 North America: Regenerative Medicine Market Snapshot
Figure 19 Key Developments in the Regenerative Medicine Market
Figure 20 Regenerative Medicine Market Ranking, By Key Player, 2018
Figure 21 MnM Dive-Vendor Comparison Matrix: Regenerative Medicine Market
Figure 22 MnM Dive-Vendor Comparison Matrix for Start-Ups: Regenerative Medicine Market
Figure 23 Novartis: Company Snapshot
Figure 24 Vericel: Company Snapshot
Figure 25 Integra Lifesciences: Company Snapshot
Figure 26 Mimedx Group: Company Snapshot
Figure 27 Stryker: Company Snapshot
Figure 28 Wright Medical: Company Snapshot
Figure 29 Osiris Therapeutics: Company Snapshot

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
  • Integra Lifesciences
  • Kite Pharma (Subsidiary of Gilead Sciences)
  • Mimedx Group
  • Novartis AG
  • Organogenesis
  • Osiris Therapeutics
  • Spark Therapeutics
  • Stryker
  • Vericel
  • Wright Medical
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4760917
Adroll
adroll